Immuno Cure BioTech
Hong Kong’s Immuno Cure completes $12M first close of Series A financing led by Gobi Partners
Hong Kong-based biotech firm Immuno Cure BioTech (Immuno Cure) announced Thursday that it has closed the $12 million tranche in the $27 million Series A fundraising round. Led by…
